| Literature DB >> 29899724 |
Peter C Fino1,2, Martina Mancini1,2, Carolin Curtze1, John G Nutt1, Fay B Horak1,2.
Abstract
Dual-task (DT) paradigms have been used in gait research to assess the automaticity of locomotion, particularly in people with Parkinson's disease (PD). In people with PD, reliance on cortical control during walking leads to greater interference between cognitive and locomotor tasks. Yet, recent studies have suggested that even healthy gait requires cognitive control, and that these cognitive contributions occur at specific phases of the gait cycle. Here, we examined whether changes in gait stability, elicited by simultaneous cognitive DTs, were specific to certain phases of the gait cycle in people with PD. Phase-dependent local dynamic stability (LDS) was calculated for 95 subjects with PD and 50 healthy control subjects during both single task and DT gait at phases corresponding to (1) heel contact-weight transfer, (2) toe-off-early swing, and (3) single-support-mid swing. PD-related DT interference was evident only for the duration of late swing and LDS during the heel contact-weight transfer phase of gait. No PD-related DT costs were found in other traditional spatiotemporal gait parameters. These results suggest that PD-related DT interference occurs only during times where cortical activity is needed for planning and postural adjustments. These results challenge our understanding of DT costs while walking, particularly in people with PD, and encourage researchers to re-evaluate traditional concepts of DT interference.Entities:
Keywords: cognitive dual-task; dynamic postural control; local dynamic stability; locomotion; lyapunov exponents
Year: 2018 PMID: 29899724 PMCID: PMC5988879 DOI: 10.3389/fneur.2018.00373
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Demographic data.
| Controls | PD | ||
|---|---|---|---|
| N | 50 | 95 | |
| % Female | 38 | 32 | |
| Age (years) | 67.8 (8.0) | 68.7 (7.7) | 0.947 |
| Height (cm) | 171.7 (9.8) | 174.2 (10.2) | 0.176 |
| Mass (kg) | 73.8 (14.6) | 79.5 (15.2) | |
| miniBEST | 24.6 (2.2) | 18.4 (4.7) | |
| TUG time (s) | 18.3 (3.1) | 23.2 (10.0) | |
| MoCA | 26.8 (1.9) | 25.5 (3.6) | |
| SCOPA-COG | 32.0 (3.5) | 28.1 (5.6) | |
| Fall in the past year (%) | 12 | 38 | |
| Disease duration (years) | – | 7.0 (5.2) | |
| MDS-UPDRS part III | – | 40.4 (12.9) | |
| PIGD score | – | 5.0 (3.2) | |
| H&Y (range) | – | 2–3 | |
| N with freezing of gait | – | 26 |
Where applicable, groups were compared using independent sample t-tests and a significance level of 0.05.
Bold values indicate significant differences between PD and control subjects.
PD, Parkinson’s disease; miniBEST, mini Balance Evaluation Systems Test; MoCA, Montreal Cognitive Assessment; PIGD, Posture Instability and Gait Disability.
Univariate means (SD) of each outcome stratified by group and condition.
| Single task | Dual task | |||
|---|---|---|---|---|
| Mean | SD | Mean | SD | |
| Control | 1.12 | 0.14 | 0.95 | 0.17 |
| PD | 0.93 | 0.20 | 0.78 | 0.19 |
| Control | 1.19 | 0.08 | 1.11 | 0.10 |
| PD | 0.99 | 0.19 | 0.89 | 0.19 |
| Control | 1.04 | 0.13 | 1.07 | 0.15 |
| PD | 1.07 | 0.16 | 1.09 | 0.15 |
| Control | 22.5 | 3.9 | 24.6 | 3.9 |
| PD | 23.9 | 4.8 | 26.7 | 6.2 |
| Control | 51.2 | 4.8 | 48.1 | 5.4 |
| PD | 49.2 | 5.6 | 46.4 | 6.4 |
| Control | 26.5 | 3.3 | 27.4 | 3.3 |
| PD | 27.0 | 3.3 | 27.0 | 3.7 |
| Control | 36 | 7 | 35 | 8 |
| PD | 32 | 10 | 29 | 8 |
| Control | 34 | 8 | 31 | 8 |
| PD | 29 | 11 | 26 | 9 |
| Control | 93 | 9 | 89 | 10 |
| PD | 90 | 11 | 88 | 11 |
| Control | 0.15 | 0.04 | 0.13 | 0.04 |
| PD | 0.13 | 0.04 | 0.12 | 0.04 |
| Control | 0.07 | 0.02 | 0.08 | 0.02 |
| PD | 0.08 | 0.02 | 0.08 | 0.02 |
| Control | 0.11 | 0.02 | 0.11 | 0.02 |
| PD | 0.12 | 0.02 | 0.11 | 0.02 |
| Control | 0.30 | 0.07 | 0.34 | 0.08 |
| PD | 0.35 | 0.07 | 0.37 | 0.09 |
.
PD, Parkinson’s disease.
Results from the linear mixed models for each stability measure.
| Beta | SE | Lower CI | Upper CI | ||
|---|---|---|---|---|---|
| Intercept | 0.072 | 0.015 | 0.042 | 0.103 | <0.001 |
| Group (ref controls) | −0.006 | 0.007 | −0.019 | 0.007 | 0.390 |
| Intercept | 0.077 | 0.009 | 0.060 | 0.094 | <0.001 |
| Task (ref ST) | 0.001 | 0.003 | −0.006 | 0.008 | 0.756 |
| Gait speed | −0.003 | 0.007 | −0.017 | 0.011 | 0.681 |
| Group*Task | −0.003 | 0.004 | −0.011 | 0.004 | 0.412 |
| Intercept | 0.072 | 0.009 | 0.054 | 0.089 | <0.001 |
| Task (ref ST) | 0.004 | 0.003 | −0.002 | 0.010 | 0.163 |
| Group*Task | −0.005 | 0.003 | −0.011 | 0.002 | 0.178 |
| Intercept | 0.471 | 0.031 | 0.410 | 0.533 | 0.000 |
| Task (ref ST) | 0.009 | 0.013 | −0.017 | 0.035 | 0.486 |
| Group (ref controls) | 0.020 | 0.014 | −0.007 | 0.048 | 0.142 |
| Group*Task | −0.011 | 0.015 | −0.041 | 0.018 | 0.452 |
Lower and upper 95% confidence intervals (CI) for beta are also presented. Bold values indicate significant effects at .
Figure 1Median dual-task changes (DTC) as percentages (%DTC) and IQRs for phase-dependent local dynamic stability (LDS) measures calculated at (1) heel contact—weight transfer, λHC, (2) toe off—early swing, λTO, and (3) single-support—mid swing, λMS, and traditional LDS calculated at all points within a stride, λKantz. DTCs were calculated as a percentage change with respect to single-task gait. *Phase-dependent LDS during heel contact—weight transfer, λHC, was significantly different between groups whether calculated as a linear change (see Table 3), or as a percentage change. Group differences in DTCs as percentages were not tested on other stability outcomes as the group*task interactions were not significant in the initial linear mixed models.
Results from the linear mixed models for each spatiotemporal measure.
| Beta | SE | Lower CI | Upper CI | ||
|---|---|---|---|---|---|
| Intercept | 1.12 | 0.03 | 1.07 | 1.17 | <0.001 |
| Group*Task | 0.02 | 0.02 | −0.02 | 0.06 | 0.368 |
| Intercept | 1.19 | 0.02 | 1.15 | 1.24 | <0.001 |
| Group*Task | −0.02 | 0.01 | −0.05 | 0.00 | 0.090 |
| Intercept | 1.04 | 0.02 | 0.99 | 1.08 | <0.001 |
| Task (ref ST) | 0.03 | 0.03 | −0.02 | 0.08 | 0.230 |
| Group (ref controls) | 0.04 | 0.03 | −0.02 | 0.09 | 0.157 |
| Group*Task | −0.02 | 0.03 | −0.08 | 0.04 | 0.532 |
| Intercept | 22.5 | 0.7 | 21.1 | 23.9 | <0.001 |
| Group (ref controls) | 1.4 | 0.9 | −0.3 | 3.1 | 0.107 |
| Group*Task | 0.6 | 0.5 | −0.4 | 1.7 | 0.231 |
| Intercept | 51.1 | 0.8 | 49.6 | 52.7 | <0.001 |
| Group*Task | −0.2 | 0.6 | −0.9 | 1.4 | 0.732 |
| Intercept | 26.5 | 0.5 | 25.6 | 27.5 | <0.001 |
| Group (ref controls) | −0.5 | 0.6 | −0.7 | 1.6 | 0.431 |
Lower and upper 95% confidence intervals (CI) for beta are also presented. Bold values indicate significant effects at .
Figure 2Median dual-task changes (DTC) as percentages (%DTC) and IQRs for spatiotemporal measures of gait for people with Parkinson’s disease (PD) (red) and healthy control subjects (blue). DTCs were calculated as a percentage change with respect to single-task gait. *Time spent in late swing was significantly different between groups whether calculated as a linear change (see Table 4), or as a percentage change. Group differences in DTCs as percentages were not tested on other spatiotemporal outcomes as the group*task interactions were not significant in the initial linear mixed models.
Results from the linear mixed models for measures of cognitive task performance.
| Beta | SE | Lower CI | Upper CI | ||
|---|---|---|---|---|---|
| Intercept | 35.99 | 1.23 | 33.45 | 38.30 | <0.001 |
| Task (ref ST) | −1.30 | 0.79 | −2.86 | 0.26 | 0.103 |
| Group*Task | −1.07 | 1.00 | −3.00 | 0.92 | 0.299 |
| Intercept | 33.5 | 1.29 | 30.96 | 36.04 | <0.001 |
| Group*Task | −0.29 | 1.01 | −2.28 | 1.69 | 0.771 |
| Intercept | 92.5 | 14.7 | 89.6 | 95.4 | <0.001 |
| Group (ref controls) | −2.6 | 1.8 | −6.2 | 0.9 | 0.149 |
| Group*Task | −1.4 | 1.6 | −1.8 | 4.6 | 0.399 |
Lower and upper 95% confidence intervals (CI) for beta are also presented. Bold values indicate significant effects at .
Figure 3Median dual-task changes (DTC) as percentages (%DTC) and IQRs for cognitive outcomes for people with Parkinson’s disease (PD) (red) and healthy control subjects (blue). DTCs were calculated as a percentage change with respect to seated. Group differences in DTCs as percentages were not tested for any cognitive outcome as no group*task interactions were significant in the initial linear mixed models.
Spearman correlation coefficients and p-values for comparisons between the %DTC of λHC and clinical characteristics in subjects with Parkinson’s disease.
| Disease duration | MDS-UPDRS part III | Posture Instability and Gait Disability | ||||
|---|---|---|---|---|---|---|
| ρ | ρ | ρ | ||||
| %DTC λHC | −0.011 | 0.917 | 0.091 | 0.384 | 0.063 | 0.549 |
| %DTC time in late swing | 0.039 | 0.709 | 0.075 | 0.475 | 0.109 | 0.294 |
Figure 4Radar plots of the absolute value of Spearman’s correlation coefficients between demographic and clinical outcomes and the %DTCs of λHC (top) or time in late swing (bottom). The dashed red and blue circles indicate the critical ρ value for p = 0.05 for Parkinson’s disease (PD) and control groups, respectively. The %DTC for time in late swing was significantly associated with TUG time in controls only (ρ = 0.41, p = 0.004). There were no other significant correlations (p > 0.05).